The American Journal of Managed Care

Medicare High-Value Drug List Model Could Lower Out-of-Pocket Costs for 4 in 10 Beneficiaries

The proposed Medicare High-Value Drug List Model, also known as the Medicare $2 Drug List, could have modestly reduced out-of-pocket costs for 38% of beneficiaries if implemented in 2021. To do so, ...
Forbes

How A Future Harris Administration Could Expand Medicare Drug Pricing Provisions

WASHINGTON DC: Vice President Kamala Harris speaks at a White House event in August 2023 celebrating the selection of the first 10 drugs for price negotiation by Medicare. (Photo by Nathan ...
CBS News

Medicare's new $2,000 prescription drug cap goes into effect. Here's how it works.

Starting Jan. 1, 2025, millions of Americans who get their prescription drugs through Medicare could get a major financial break when a $2,000 out-of-pocket spending cap on medications goes into ...
Business Wire

New Study: Patients Unlikely to See Out-Of-Pocket Drug Savings from the Inflation Reduction Act

WASHINGTON--(BUSINESS WIRE)--New research contradicts promises of savings at the pharmacy counter for Medicare beneficiaries from the Inflation Reduction Act’s (IRA) drug pricing provisions. In fact, ...
Business Wire

Study Finds Trump’s Most Favored Nation Drug Proposal Could Still Raise Out-of-Pocket Costs Without PBM Reform

BOSTON--(BUSINESS WIRE)--Out-of-pocket drug costs for seniors may rise under President Trump’s Most Favored Nation (MFN) proposal if policymakers do not address the role of pharmacy benefit managers ...